1. The Ethical Dilemma Of Patient-Funded Trials Influenced by an article on the National Post website, this looks deeper into the ethical dilemma surrounding clinical trials when patients have to pay to participate in them. 2. Genomes, Big Data and the Journey to Precision Medicine The industry’s education of genomes has grown, but we must […]
US-based Clinical Research, Multi-Tasking & More! What We’re Talking About This Week
1. US-based clinical research spending drops 32%, show new data The August issue of Life Science Compliance Update reveals the results from an analysis of the U.S. government’s Open Payments and they are discussed here. Is US-based clinical research suffering because of the Sunshine Act? 2. Data Manager, Trainer, Quality Associate…Which Hat Shall I Wear Today? Greg Ventura, […]
Risk-Based Monitoring, Digital Health in Studies & More! What We’re Talking About This Week
1. Lessons Learned From A Venture Into Risk-Based Monitoring An in depth look into risk-based monitoring and tips on how to make sure your clinical trial is conducted in an appropriate manner. 2. Clinical researchers are slow to utilize digital health to help with studies Researchers are not staying on trend with mobile technology and are […]
Ebola Vaccine, Drug Sales and More! What We’re Talking About This Week
1. How Ebola vaccine success could reshape clinical-trial policy The Ebola concerns continue and this article sums up the results of a trial in New Guinea. A successful ebola vaccine against the dreaded disease could be found soon! 2. Drug sales expected to top $1.3T in 2018 Yes, that is a T for trillion, and by 2018, […]